Douglas L. Braunstein, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 3,909 shares at $62.63 ($245K) on 2019-10-15, disclosed to the SEC on 2019-10-15.
Open-market sale of $245k EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TALK | BUY | 2021-06-24 | $50.0M | — | Filing → |
| HCII | SELL | 2021-04-14 | $0 | — | Filing → |
| EGRX | SELL | 2019-10-15 | $984K | — | Filing → |